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X-linked mental retardation (XLMR)-associated mutations
affect the activity of the aristaless-related homeobox
protein, Arx
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Arx is expressed in the developing forebrain of vertebrates.
Arx mutations are associated with human diseases such as
XLMR. Arx is thought to be a repressor due to the presence of
a conserved octapeptide (OP) motif. The OP has been
previously shown to mediate repression via binding to the
corepressor Groucho. Arx function was assayed using Gal4-
Arx fusion constructs in a Gal4-responsive luciferase reporter
system. Constructs were injected or co-injected with the
Xenopus Groucho homolog Grg4. Mutations tested were:
wildtype Arx, a L33P point mutation within the OP, an OP
deletion, and a C-terminal deletion. L33P and the C-terminal
deletion are mutations found in XLMR. We found that Arx
repressed activity of the reporter in a dose-dependent manner.
L33P decreased repression of Arx by ¨2-fold as did the OP
deletion. Co-injection of Grg4 enhanced repression activity of
Arx by ¨4-fold but had no effect on the OP mutants. The C-
terminal deletion decreased repression ¨3-fold, indicating that
this region is also important for repression. Combination of
L33P and the C-terminal deletion resulted in complete loss of
repression, suggesting that both regions are important for
repression. In this system, Arx is a transcriptional repressor that
contains two individual repression domains: the OP which
mediates repression through Grg4 and contains an important
conserved L33 residue and the C-terminal region. Therefore,
XLMR-associated mutations affect the transcriptional repres-
sion activity of Arx, providing insight into the role Arx may
play in disease.
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The receptor for advanced glycation end products
(RAGE) is a member of the immunoglobin superfamily of
multiligand cell surface molecules. Signal transduction
pathways activated upon ligand binding coordinate mechan-
isms associated with host defense, tissue remodeling, and
inflammation. RAGE becomes highly expressed in pulmo-
nary epithelium transitioning from Type II to Type I cells,
and receptors are upregulated in the presence of ligand,
however, the regulation and functional role of RAGE during
development is less clear. RAGE expression was assessed
by immunohistochemistry in mouse lungs from embryonic
day (E) 13.5 to postnatal day (PN) 10. Transcriptional
regulation of RAGE was assessed by transfection of human
pulmonary adenocarcinoma cells with a reporter containing
751-bp of the mouse RAGE promoter and the early zinc-
finger transcription factor Egr-1. RAGE was initially
detected in thinning epithelial cells at E17.5. While minimal
co-localization of RAGE and Type II cell markers was
observed, staining markedly increased through PN 10 in
Type I cells during alveolarization. By RT-PCR, Egr-1
expression was elevated 48-fold in rat Type I cells following
exposure to GA-AGE, an AGE moiety that binds RAGE
with high affinity. Interestingly, Egr-1 transcriptionally
inhibited the RAGE promoter in vitro. These results support
the concept that Egr-1 may function in a negative feedback
loop whereby the pattern of RAGE expression is controlled
in Type I epithelial cells. It is possible that Egr-1-mediated
regulation of RAGE contributes to normal morphogenic
events and fibrosis, inflammation, and pulmonary remodel-
ing during disease.
doi:10.1016/j.ydbio.2006.04.164
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Integration of foreign DNA into mouse genome by
conventional pronuclear injection method is random with
unpredictable gene copies. In order to circumvent this
disadvantage, we develop a method to insert clones up to
250 kb into mouse genome site-specifically with single copy
by using the combination of recombineering and recombi-
nase mediated cassette exchange (RMCE). First, recombi-
neering is the homologous recombination promoting by
phage recombination system and a powerful tool to
manipulate bacterial artificial chromosome (BAC) DNA.
Second, Cre/loxP recombinase system is widely used to
modify mouse genome site-specifically by targeting vectors
in vivo. A DNA cassette flanked by two mutant loxP sites
on chromosome can be exchanged for another cassette
located on targeting vectors by a double reciprocal recom-
bination and is named RMCE. Taking the advantage of
positive and negative selection of HPRT (Hypoxanthine-
Guanine Phosphoribosyl Transferase) gene by HAT and 6-
thioguanine respectively, we generated several mouse ES
(embryonic stem) cell lines containing mutant loxP sites at
HPRT locus. Also, we modified a 250 kb BAC by
recombineering and construct plasmid containing cassette
flanked by mutant loxP. By using the BAC and plasmid
vectors, we successfully targeted the ES cell with this
cassette exchange strategy. This method will be extremely
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